InnoCan submits new patent applications for advanced pain relief technology
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Olverembatinib is the first and only third-generation BCR-ABL inhibitor approved in China for the treatment of adult patients with tyrosine kinase inhibitors
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
The latest extension of Masimo and Philips’ ongoing collaboration will help enable clinicians to make quick and informed decisions without the need for additional monitoring equipment
The product is expected to be launched in June 2023
Continues to Expand its Presence in South India
Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Subscribe To Our Newsletter & Stay Updated